Highlights
NASDAQ: CTIC       Cti Biopharm Corp
Last Price Today's Change   Day's Range   Trading Volume
2.27   -0.04 (1.73%)  2.27 - 2.43  410,300

Overview

 
Avg Volume (4 weeks):719,647
4 Weeks Range:2.27 - 2.60
4 Weeks Price Volatility (%):
0.00%
52 Weeks Range:0.963 - 4.13
52 Weeks Price Volatility (%):
41.27%
Average Price Target: 3.00
Price Target Upside/Downside: +0.73

Headlines



No recent Headlines for this stock.


Business Background

CTI Biopharma Corp is a biopharmaceutical company focused on the development and commercialization of less toxic, more effective cancer therapies. The company's therapeutic area is blood-related cancers. One of the company's products, Pixantrone (PIXUVRI), received conditional marketing approval in the EU in 2012 to treat refractory aggressive B-cell non-Hodgkin lymphoma. Another product is Pacritinib, an oral tyrosine kinase inhibitor to treat mutations such as Janus associated kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3).

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

6516  3254  847  220 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 TRCH 9.92+3.65 
 WISH 13.50+2.10 
 AMC 55.69-3.57 
 GSAT 1.51+0.22 
 SNDL 0.913-0.01 
 TWO 8.01+0.25 
 AEI 6.12+1.21 
 XLF 35.91+0.68 
 AAPL 132.30+1.84 
 SPY 420.86+5.94